Post-transplant lymphoproliferative disorder: a heterogeneous conundrum - response to Weisenburger DD & Gross TG

Br J Haematol. 2017 Dec;179(5):856-857. doi: 10.1111/bjh.14272. Epub 2016 Jul 29.

Authors

Dejan Radeski¹, Francesca Montanari², Bachir Alobeid³, Owen A O'Connor⁴, Govind Bhagat³

Affiliations

¹ School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia.
² NYU Cancer Institute, New York University School of Medicine, New York, NY, USA.
³ Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.
⁴ Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA.

PMID: 27471184
DOI: 10.1111/bjh.14272

No abstract available

Keywords: classification; gene expression profiling; immunosuppression; post-transplant lymphoproliferative disorders.

Publication types

Letter
Comment

MeSH terms

Epstein-Barr Virus Infections*
Humans
Kidney Transplantation
Lymphoma
Lymphoproliferative Disorders*